Community oncology practices are forced to navigate dramatic market shifts. Mergers and acquisitions, fee schedule changes, increased competition with hospitals, and Covid-19 disruptions are a few recent developments making impacts. Boosting EBITDA in the near-term is critical to best position your organization for a sale, merger, partnership, and/or long-term viability.

Download this white paper to learn about:

• Billing headaches that affect EBITDA the most in community oncology
• The right analytics tools for managing financial performance
• Automating prior authorization and other needed functionality
• Improving payor denial management
• And more